Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Celanese Corporation Reports Second Quarter 2018 Earnings; Increases Full Year 2018 Outlook

CE

Celanese Corporation Reports Second Quarter 2018 Earnings; Increases Full Year 2018 Outlook

Celanese Corporation (NYSE: CE), a global specialty materials company, today reported GAAP diluted earnings per share of $2.52, a second quarter record, and highest ever adjusted earnings per share of $2.90. Net sales in the quarter expanded 22 percent year over year to $1.8 billion. Robust pricing across the businesses led to the success this quarter. The Acetyl Chain captured opportunities by rapidly flexing its expansive network amid both industry supply disruptions and improved utilization rates. Engineered Materials continued to demonstrate the strength of its pipeline model through project commercializations, improved product mix, and higher pricing.

Second Quarter 2018 Financial Highlights:

             
        Three Months Ended
June 30,
        2018           2017
        (As Adjusted)
(unaudited)
(In $ millions)
Operating Profit (Loss)
Engineered Materials 114 105
Acetate Tow 39 41
Acetyl Chain
Industrial Specialties 22 26
Acetyl Intermediates         251         109  
Subtotal         273         135  
Other Activities         (68 )       (63 )
Total         358         218  
 
      Three Months Ended
June 30,
2018   2017
(unaudited)
(In $ millions, except per share data)
Net Earnings (Loss) 345 233
 
Adjusted EBIT (1)(2)
Engineered Materials 175 150
Acetate Tow 77 71
Acetyl Chain
Industrial Specialties 25 26
Acetyl Intermediates   252     106  
Subtotal   277     132  
Other Activities   (38 )   (27 )
Total   491     326  
 
Equity Earnings, Cost-Dividend Income, Other Income (Expense)
Engineered Materials 54 38
Acetate Tow 33 28
 
Operating EBITDA(1) 573 401
Diluted EPS - continuing operations $ 2.52 $ 1.72
Diluted EPS - total $ 2.52 $ 1.66
Adjusted EPS(1) $ 2.90 $ 1.79
 
Net cash provided by (used in) investing activities (96 ) (325 )
Net cash provided by (used in) financing activities (254 ) 21
Net cash provided by (used in) operating activities 585 298
Free cash flow(1) 500 240

___________________________

(1) See "Non-US GAAP Financial Measures" below.

(2) The Company's discussion of adjusted earnings includes use of terms such as "segment income" and "core income". Those non-GAAP terms are defined below and reconciled in our Non-US GAAP Financial Measures and Supplemental Information document referenced below.

Second Quarter 2018 Highlights:

  • Initiated the closure of the acetate tow manufacturing unit in Ocotlán, Jalisco, Mexico. The consolidation will strengthen competitive positioning, reduce costs, and align production capacities with anticipated industry demand.
  • Commercialized 733 Engineered Materials projects in the second quarter of 2018, a 34 percent increase over the second quarter of last year. On pace to deliver close to 3,000 project wins for the full year.
  • Launched the “Regulated Product” (RP) acetate tow category with an increased level of regulatory support and product testing, along with raw material and product traceability, for United States grades used in tobacco products.
  • Generated all-time record free cash flow of $500 million in the quarter on the strength of underlying earnings growth and strong accounts receivable and inventory performance relative to earnings levels.
  • Signed a Letter of Intent with Chengzhi Shareholding Co., Ltd. to sell the Nanjing ethanol unit to Chengzhi and advance the use of acetic acid-based ethanol as a clean energy source utilizing the TCX® ethanol process technology.
  • Announced capital efficient technology process improvements across acetyls manufacturing plants that add 140 kt of acetic acid and 150 kt of VAM through 2020.
  • Announced the addition of a new GUR® ultra-high molecular weight polyethylene (UHMW-PE) production line at the Nanjing, China manufacturing facility that is expected to add 15 kt of capacity by 2019.
  • Announced a capital efficient multi-phase de-bottlenecking project for POM production lines with completion of Phase I de-bottlenecking in 2020 and Phase II completion shortly thereafter.

Second Quarter 2018 Business Segment Overview

Engineered Materials (EM)

Engineered Materials delivered its second highest net sales of $664 million in the quarter, 22 percent higher than the prior year. GAAP operating profit in the second quarter was $114 million and segment income was $175 million. This growth in adjusted earnings resulted from the success of the opportunity pipeline, improved product mix, and recent acquisitions. 733 new projects were commercialized in the quarter, 34 percent more than in the prior year second quarter. Volume grew year over year with higher project commercializations, the Omni acquisition, and growth in Asia and the Americas. Growing demand for the ability to customize solutions supported by a broad range of polymers continues to drive growth for EM. Operating profit margin and segment income margin both dipped slightly lower year over year mainly due to acquisitions and cost inflation, partially offset by higher pricing across products. Affiliate earnings were $53 million and increased from the same quarter last year driven by MTBE pricing and higher economic interest in the Ibn Sina joint venture.

Acetate Tow

Acetate Tow GAAP operating profit was $39 million and segment income was $77 million in the second quarter. Volume and price in the quarter declined in the tow product line compared to the same quarter in 2017 due to lower industry capacity utilization and were partially offset by mix and productivity gains. Affiliate earnings grew by $5 million to $33 million due to the timing of dividend payments from the Chinese joint ventures.

Acetyl Chain

The Acetyl Chain’s net sales of $1.0 billion in the second quarter represented a 27 percent increase over the same quarter in 2017 driven by continued commercial momentum in the business. GAAP operating profit was $273 million and core income more than doubled year over year to $277 million, both all-time highs. Sustained improvements in the acetyl industry fundamentals allowed the business to considerably increase network activations compared to the same quarter in 2017. Record GAAP operating margin and core income margin of 26 percent were achieved through price increases across products and regions, led by acetic acid in Asia, which more than offset increases in raw material costs. Demand continues to be strong across all product lines and in all regions supporting higher volume and strong earnings.

Cash Flow and Tax

Operating cash flow in the second quarter was $585 million. Free cash flow was $500 million, driven by robust underlying business results and strong accounts receivable and inventory performance relative to earnings. The company is on pace to deliver free cash flow exceeding $1 billion for all of 2018. Capital expenditures were $79 million in the quarter for a total of $165 million in the first half, driven by a number of organic capacity expansion projects across the businesses. A total of $173 million in cash was returned to shareholders, with $100 million in share buybacks and $73 million in dividends.

The effective US GAAP tax rate was 22 percent compared to 14 percent in the second quarter of 2017 driven mainly by adjustments to valuation allowances on foreign tax credits. The tax rate for adjusted EPS was 14 percent, 2 percent lower year over year for the quarter, primarily due to the Tax Cuts and Jobs Act.

Outlook

"Success in the second quarter of 2018 came from applying our unique commercial approach to steady demand increments and tight market fundamentals across our businesses," said Mark Rohr, chairman and chief executive officer. "In Engineered Materials, the project pipeline model continues to advance by custom-matching our full breadth of polymer solutions to individual customer needs with increasing efficiency. In the Acetyl Chain, a continuation of tightened supply and demand dynamics has presented new opportunities to apply our business model. For the year, Acetate Tow earnings are expected to remain relatively flat to the prior year. In the Acetyl Chain we anticipate the momentum to carry into the third quarter with normal seasonality in the fourth quarter. Considering these factors, we are increasing our expectations for 2018 adjusted earnings to roughly $10.50-$10.75 per share and free cash flow greater than $1 billion."

We are unable to reconcile forecasted adjusted earnings per share growth to US GAAP diluted earnings per share without unreasonable efforts because a forecast of Certain Items, such as mark-to-market pension gains/losses, is not practical.

The Company's earnings presentation and prepared remarks related to the second quarter results will be posted on its website at www.celanese.com under Investor Relations/Events and Presentations after market close on July 19, 2018. Information about Non-US GAAP measures is included in a Non-US GAAP Financial Measures and Supplemental Information document posted on the website and available at the link below. See "Non-GAAP Financial Measures" below.

Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our businesses use the full breadth of Celanese's global chemistry, technology and commercial expertise to create value for our customers, employees, shareholders and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,700 employees worldwide and had 2017 net sales of $6.1 billion. For more information about Celanese Corporation and its product offerings, visit  www.celanese.com  or our blog at  www.celaneseblog.com .

Forward-Looking Statements

This release may contain "forward-looking statements," which include information concerning the Company's plans, objectives, goals, strategies, future revenues, synergies, performance, capital expenditures, financing needs and other information that is not historical information. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the Company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the results expressed or implied in the forward-looking statements contained in this release. These risks and uncertainties include, among other things: changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate; the length and depth of product and industry business cycles, particularly in the automotive, electrical, textiles, electronics and construction industries; changes in the price and availability of raw materials, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources; the ability to pass increases in raw material prices on to customers or otherwise improve margins through price increases; the ability to maintain plant utilization rates and to implement planned capacity additions and expansions; the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants; the ability to identify desirable potential acquisition targets and to consummate acquisition or investment transactions consistent with the Company's strategy; increased price competition and the introduction of competing products by other companies; market acceptance of our technology; the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to the Company; changes in tariffs, tax rates or legislation; changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property; compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, cyber security incidents, terrorism or political unrest or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the occurrence of acts of war or terrorist incidents or as a result of weather or natural disasters; potential liability for remedial actions and increased costs under existing or future environmental regulations, including those relating to climate change; potential liability resulting from pending or future litigation, or from changes in the laws, regulations or policies of governments or other governmental activities in the countries in which we operate; changes in currency exchange rates and interest rates; our level of indebtedness, which could diminish our ability to raise additional capital to fund operations or limit our ability to react to changes in the economy or the chemicals industry; and various other factors discussed from time to time in the Company's filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Non-GAAP Financial Measures

Presentation

This document presents the Company's four business segments, Engineered Materials, Acetate Tow, Industrial Specialties and Acetyl Intermediates, with one subtotal reflecting our core, the Acetyl Chain, which is based on similarities among customers, business models and technical processes. The Acetyl Chain includes the Company's Acetyl Intermediates segment and the Industrial Specialties segment.

Use of Non-US GAAP Financial Information

This release uses the following Non-US GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, adjusted earnings per share and free cash flow. These measures are not recognized in accordance with US GAAP and should not be viewed as an alternative to US GAAP measures of performance or liquidity. The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin is operating margin; for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; and for free cash flow is net cash provided by (used in) operations.

Definitions of Non-US GAAP Financial Measures

  • Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8 of our Non-US GAAP Financial Measures and Supplemental Information document). We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales.
  • Adjusted EBIT by core (i.e., the Acetyl Chain) may also be referred to by management as core income. Adjusted EBIT margin by core may also be referred to by management as core income margin. Adjusted EBIT by business segment may also be referred to by management as segment income. Adjusted EBIT margin by business segment may also be referred to by management as segment income margin.
  • Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization.
  • Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.

    Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a of our Non-US GAAP Financial Measures and Supplemental Information document summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.
  • Free cash flow is a liquidity measure used by the Company and is defined by the Company as cash flow from operations, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our methanol joint venture, Fairway Methanol LLC ("Fairway").

Reconciliation of Non-US GAAP Financial Measures

Reconciliations of the Non-US GAAP financial measures used in this press release to the comparable US GAAP financial measure, together with information about the purposes and uses of Non-US GAAP financial measures, are included in our Non-US GAAP Financial Measures and Supplemental Information document filed as an exhibit to our Current Report on Form 8-K filed with the SEC on or about July 19, 2018 and also available on our website at www.celanese.com under Financial Information, Non-GAAP Financial Measures, or at this link: http://investors.celanese.com/interactive/lookandfeel/4103411/Non-GAAP.PDF .

Results Unaudited

The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

Supplemental Information

Additional information about our prior period performance is included in our Quarterly Reports on Form 10-Q and in our Non-US GAAP Financial Measures and Supplemental Information document.

     

Consolidated Statements of Operations - Unaudited

 
Three Months Ended
June 30,
2018   2017
(As Adjusted)
(In $ millions, except share and per share data)
Net sales 1,844 1,510
Cost of sales (1,323 ) (1,145 )
Gross profit 521 365
Selling, general and administrative expenses (136 ) (117 )
Amortization of intangible assets (7 ) (5 )
Research and development expenses (18 ) (17 )
Other (charges) gains, net (3 ) (2 )
Foreign exchange gain (loss), net 3 (4 )
Gain (loss) on disposition of businesses and assets, net (2 ) (2 )
Operating profit (loss) 358 218
Equity in net earnings (loss) of affiliates 56 38
Non-operating pension and other postretirement employee benefit (expense) income 26 22
Interest expense (32 ) (30 )
Interest income 1
Dividend income - cost investments 34 29
Other income (expense), net   3  
Earnings (loss) from continuing operations before tax 442 281
Income tax (provision) benefit (97 ) (40 )
Earnings (loss) from continuing operations 345   241  
Earnings (loss) from operation of discontinued operations (9 )
Income tax (provision) benefit from discontinued operations   1  
Earnings (loss) from discontinued operations   (8 )
Net earnings (loss) 345 233
Net (earnings) loss attributable to noncontrolling interests (1 ) (2 )
Net earnings (loss) attributable to Celanese Corporation 344   231  
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations 344 239
Earnings (loss) from discontinued operations   (8 )
Net earnings (loss) 344   231  
Earnings (loss) per common share - basic
Continuing operations 2.54 1.73
Discontinued operations   (0.06 )
Net earnings (loss) - basic 2.54   1.67  
Earnings (loss) per common share - diluted
Continuing operations 2.52 1.72
Discontinued operations   (0.06 )
Net earnings (loss) - diluted 2.52   1.66  
Weighted average shares (in millions)
Basic 135.6 138.6
Diluted 136.3 139.0
 
       

Consolidated Balance Sheets - Unaudited

 

As of
June 30,
2018

As of
December 31,
2017

(In $ millions)
ASSETS
Current Assets
Cash and cash equivalents 708 576
Trade receivables - third party and affiliates, net 1,156 986
Non-trade receivables, net 289 244
Inventories 917 900
Marketable securities, at fair value 32 32
Other assets 51   54  
Total current assets 3,153   2,792  
Investments in affiliates 963 976
Property, plant and equipment, net 3,724 3,762
Deferred income taxes 163 366
Other assets 392 338
Goodwill 1,069 1,003
Intangible assets, net 325   301  
Total assets 9,789   9,538  
LIABILITIES AND EQUITY
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates 366 326
Trade payables - third party and affiliates 819 807
Other liabilities 314 354
Income taxes payable 111   72  
Total current liabilities 1,610   1,559  
Long-term debt, net of unamortized deferred financing costs 3,228 3,315
Deferred income taxes 248 211
Uncertain tax positions 149 156
Benefit obligations 557 585
Other liabilities 210 413
Commitments and Contingencies
Stockholders' Equity
Preferred stock
Common stock
Treasury stock, at cost (2,131 ) (2,031 )
Additional paid-in capital 208 175
Retained earnings 5,491 4,920
Accumulated other comprehensive income (loss), net (188 ) (177 )
Total Celanese Corporation stockholders' equity 3,380 2,887
Noncontrolling interests 407   412  
Total equity 3,787   3,299  
Total liabilities and equity 9,789   9,538  
 

Non-US GAAP Financial Measures and Supplemental Information

July 19, 2018

In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis.

Purpose

The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-US GAAP financial measures. This document is updated quarterly.

Presentation

This document presents the Company's four business segments, Engineered Materials, Acetate Tow, Industrial Specialties and Acetyl Intermediates, with one subtotal reflecting our core, the Acetyl Chain, which is based on similarities among customers, business models and technical processes. The Acetyl Chain includes the Company's Industrial Specialties segment and Acetyl Intermediates segment.

Use of Non-US GAAP Financial Measures

From time to time, management may publicly disclose certain numerical "non-GAAP financial measures" in the course of our earnings releases, financial presentations, earnings conference calls, investor and analyst meetings and otherwise. For these purposes, the Securities and Exchange Commission ("SEC") defines a "non-GAAP financial measure" as a numerical measure of historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that effectively exclude amounts, included in the most directly comparable measure calculated and presented in accordance with US GAAP, and vice versa for measures that include amounts, or are subject to adjustments that effectively include amounts, that are excluded from the most directly comparable US GAAP measure so calculated and presented. For these purposes, "GAAP" refers to generally accepted accounting principles in the United States.

Non-GAAP financial measures disclosed by management are provided as additional information to investors, analysts and other parties because the Company believes them to be important supplemental measures for assessing our financial and operating results and as a means to evaluate our financial condition and period-to-period comparisons. These non-GAAP financial measures should be viewed as supplemental to, and should not be considered in isolation or as alternatives to, net earnings (loss), operating profit (loss), operating margin, cash flow from operating activities (together with cash flow from investing and financing activities), earnings per share or any other US GAAP financial measure. These non-GAAP financial measures should be considered within the context of our complete audited and unaudited financial results for the given period, which are available on the Investor Relations/Financial Information/SEC Filings page of our website, www.celanese.com . The definition and method of calculation of the non-GAAP financial measures used herein may be different from other companies' methods for calculating measures with the same or similar titles. Investors, analysts and other parties should understand how another company calculates such non-GAAP financial measures before comparing the other company's non-GAAP financial measures to any of our own. These non-GAAP financial measures may not be indicative of the historical operating results of the Company nor are they intended to be predictive or projections of future results.

Pursuant to the requirements of SEC Regulation G, whenever we refer to a non-GAAP financial measure, we will also present in this document, in the presentation itself or on a Form 8-K in connection with the presentation on the Investor Relations/Financial Information/Non-GAAP Financial Measures page of our website, www.celanese.com , to the extent practicable, the most directly comparable financial measure calculated and presented in accordance with GAAP, along with a reconciliation of the differences between the non-GAAP financial measure we reference and such comparable GAAP financial measure.

This document includes definitions and reconciliations of non-GAAP financial measures used from time to time by the Company.

Specific Measures Used

This document provides information about the following non-GAAP measures: adjusted EBIT, adjusted EBIT margin, operating EBITDA, operating EBITDA margin, operating profit (loss) attributable to Celanese Corporation, adjusted earnings per share, net debt, free cash flow and return on invested capital (adjusted). The most directly comparable financial measure presented in accordance with US GAAP in our consolidated financial statements for adjusted EBIT and operating EBITDA is net earnings (loss) attributable to Celanese Corporation; for adjusted EBIT margin and operating EBITDA margin is operating margin; for operating profit (loss) attributable to Celanese Corporation is operating profit (loss); for adjusted earnings per share is earnings (loss) from continuing operations attributable to Celanese Corporation per common share-diluted; for net debt is total debt; for free cash flow is net cash provided by (used in) operations; and for return on invested capital (adjusted) is net earnings (loss) attributable to Celanese Corporation divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity.

Definitions

  • Adjusted EBIT is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense and taxes, and further adjusted for Certain Items (refer to Table 8). We believe that adjusted EBIT provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of unusual, non-operational or restructuring-related activities that affect comparability. Our management recognizes that adjusted EBIT has inherent limitations because of the excluded items. Adjusted EBIT is one of the measures management uses for planning and budgeting, monitoring and evaluating financial and operating results and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted EBIT on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information. Adjusted EBIT margin is defined by the Company as adjusted EBIT divided by net sales. Adjusted EBIT margin has the same uses and limitations as Adjusted EBIT.
  • Adjusted EBIT by core (i.e. the Acetyl Chain) may also be referred to by management as core income. Adjusted EBIT margin by core may also be referred to by management as core income margin. Adjusted EBIT by business segment may also be referred to by management as segment income. Adjusted EBIT margin by business segment may also be referred to by management as segment income margin.
  • Operating EBITDA is a performance measure used by the Company and is defined by the Company as net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, plus refinancing expense, taxes and depreciation and amortization, and further adjusted for Certain Items, which Certain Items include accelerated depreciation and amortization expense. Operating EBITDA is equal to adjusted EBIT plus depreciation and amortization. We believe that Operating EBITDA provides transparent and useful information to investors, analysts and other parties in evaluating our operating performance relative to our peer companies. Operating EBITDA margin is defined by the Company as Operating EBITDA divided by net sales. Operating EBITDA margin has the same uses and limitations as Operating EBITDA.
  • Operating profit (loss) attributable to Celanese Corporation is defined by the Company as operating profit (loss), less earnings (loss) attributable to noncontrolling interests ("NCI"). We believe that operating profit (loss) attributable to Celanese Corporation provides transparent and useful information to management, investors, analysts and other parties in evaluating our core operational performance. Operating margin attributable to Celanese Corporation is defined by the Company as operating profit (loss) attributable to Celanese Corporation divided by net sales. Operating margin attributable to Celanese Corporation has the same uses and limitations as Operating profit (loss) attributable to Celanese Corporation.
  • Adjusted earnings per share is a performance measure used by the Company and is defined by the Company as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, Certain Items, and refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method. We believe that adjusted earnings per share provides transparent and useful information to management, investors, analysts and other parties in evaluating and assessing our primary operating results from period-to-period after removing the impact of the above stated items that affect comparability and as a performance metric in the Company's incentive compensation plan. We do not provide reconciliations for adjusted earnings per share on a forward-looking basis (including those contained in this document) when we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of Certain Items, such as mark-to-market pension gains and losses, that have not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.

    Note: The income tax expense (benefit) on Certain Items ("Non-GAAP adjustments") is determined using the applicable rates in the taxing jurisdictions in which the Non-GAAP adjustments occurred and includes both current and deferred income tax expense (benefit). The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete recognition of GAAP items on a quarterly basis, other pre-tax items adjusted out of our GAAP earnings for adjusted earnings per share purposes and changes in management's assessments regarding the ability to realize deferred tax assets for GAAP. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust it if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. Table 3a summarizes the reconciliation of our estimated GAAP effective tax rate to the adjusted tax rate. The estimated GAAP rate excludes discrete recognition of GAAP items due to our inability to forecast such items. As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate to the adjusted tax rate for actual results.

  • Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operations, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our methanol joint venture, Fairway Methanol LLC ("Fairway"). We believe that free cash flow provides useful information to management, investors, analysts and other parties in evaluating the Company's liquidity and credit quality assessment because it provides an indication of the long-term cash generating ability of our business. Although we use free cash flow as a measure to assess the liquidity generated by our business, the use of free cash flow has important limitations, including that free cash flow does not reflect the cash requirements necessary to service our indebtedness, lease obligations, unconditional purchase obligations or pension and postretirement funding obligations.
  • Net debt is defined by the Company as total debt less cash and cash equivalents. We believe that net debt provides useful information to management, investors, analysts and other parties in evaluating changes to the Company's capital structure and credit quality assessment.
  • Return on invested capital (adjusted) is defined by the Company as adjusted EBIT, tax effected using the adjusted tax rate, divided by the sum of the average of beginning and end of the year short- and long-term debt and Celanese Corporation stockholders' equity. We believe that return on invested capital (adjusted) provides useful information to management, investors, analysts and other parties in order to assess our income generation from the point of view of our stockholders and creditors who provide us with capital in the form of equity and debt and whether capital invested in the Company yields competitive returns. In addition, achievement of certain predetermined targets relating to return on invested capital (adjusted) is one of the factors we consider in determining the amount of performance-based compensation received by our management.

Supplemental Information

Supplemental Information we believe to be of interest to investors, analysts and other parties includes the following:

  • Net sales for the Acetyl Chain and each of our business segments and the percentage increase or decrease in net sales attributable to price, volume, currency and other factors for the Acetyl Chain and each of our business segments.
  • Cash dividends received from our equity and cost investments.
  • For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside stockholders' interests are shown as NCI. Beginning in 2014, this includes Fairway for which the Company's ownership percentage is 50%. Amounts referred to as "attributable to Celanese Corporation" are net of any applicable NCI.

Recent Developments

Effective January 1, 2018, we reorganized our operating and reportable segments to align with recent structural and management reporting changes. The change reflects the movement of our food ingredients business from the Consumer Specialties reportable segment into the Engineered Materials reportable segment. The former Consumer Specialties reportable segment is being renamed the Acetate Tow segment and the former Advanced Engineered Materials reportable segment is being renamed the Engineered Materials segment. This reorganization better reflects how we manage our food ingredients' related products commercially. Engineered Materials and food ingredients are both project-based models which focus on delivering customized solutions and are led by the same senior management team. These changes in operating and reportable segments were applied retrospectively to prior periods through 2014.

Results Unaudited

The results in this document, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

             

Table 1

Adjusted EBIT and Operating EBITDA - Reconciliation of Non-GAAP Measures - Unaudited

 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17
(In $ millions)
Net earnings (loss) attributable to Celanese Corporation 344 363 843 203 226 231 183
(Earnings) loss from discontinued operations 2 13 1 4 8
Interest income (2 ) (2 ) (1 ) (1 )
Interest expense 32 33 122 31 32 30 29
Refinancing expense
Income tax provision (benefit) 97 65 213 60 57 40 56

Certain Items attributable to Celanese Corporation (Table 8)

18   13   167   57   27   18   65
Adjusted EBIT 491 474 1,356 352 345 326 333
Depreciation and amortization expense(1) 82   79   303   79   78   75   71
Operating EBITDA 573   553   1,659   431   423   401   404
 
 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17
(In $ millions)
Engineered Materials 1
Acetate Tow 3
Industrial Specialties 2 2
Acetyl Intermediates
Other Activities(2)            
Accelerated depreciation and amortization expense 4 2 2
Depreciation and amortization expense(1) 82   79   303   79   78   75   71
Total depreciation and amortization expense 86   79   305   79   80   75   71
 
______________________________
(1)  

Excludes accelerated depreciation and amortization expense as detailed in the table above, which amounts are included in Certain Items above.

(2)

Other Activities includes corporate Selling, general and administrative ("SG&A") expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

 
             

Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited

 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17
(In $ millions, except percentages)
Operating Profit (Loss) / Operating Margin              
Engineered Materials 114 17.2 % 127 19.1 % 412 18.6 % 98 16.9 % 105 18.3 % 105 19.2 % 104 20.2 %
Acetate Tow 39 24.1 % 46 27.4 % 189 28.3 % 41 26.1 % 45 28.7 % 41 25.2 % 62 32.5 %
Acetyl Chain(1) 273 26.0 % 253 24.1 % 509 15.1 % 175 19.7 % 147 17.0 % 135 16.3 % 52 6.5 %
Other Activities(2) (68 ) (83 ) (253 ) (74 ) (68 ) (63 ) (48 )
Total 358   19.4 % 343   18.5 % 857   14.0 % 240   15.1 % 229   14.6 % 218   14.4 % 170   11.6 %
Less: Net Earnings (Loss) Attributable to NCI(1) 1   2   6   1   2   2   1  
Operating Profit (Loss) Attributable to Celanese Corporation 357   19.4 % 341   18.4 % 851   13.9 % 239   15.0 % 227   14.5 % 216   14.3 % 169   11.5 %
Operating Profit (Loss) / Operating Margin Attributable to Celanese Corporation
Engineered Materials 114 17.2 % 127 19.1 % 412 18.6 % 98 16.9 % 105 18.3 % 105 19.2 % 104 20.2 %
Acetate Tow 39 24.1 % 46 27.4 % 189 28.3 % 41 26.1 % 45 28.7 % 41 25.2 % 62 32.5 %
Acetyl Chain
Industrial Specialties 22 7.6 % 23 8.4 % 85 8.3 % 15 6.0 % 19 7.2 % 26 9.9 % 25 10.2 %
Acetyl Intermediates(1) 250 29.0 % 229 26.3 % 418 15.7 % 159 22.2 % 126 18.4 % 107 16.5 % 26 4.2 %
Eliminations   (1 )        

 

 

Subtotal 272   25.9 % 251   23.9 % 503   14.9 % 174   19.6 % 145   16.8 % 133   16.1 % 51   6.4 %
Other Activities(2) (68 ) (83 ) (253 ) (74 ) (68 ) (63 ) (48 )
Total 357   19.4 % 341   18.4 % 851   13.9 % 239   15.0 % 227   14.5 % 216   14.3 % 169   11.5 %
Equity Earnings, Cost-Dividend Income, Other Income (Expense) Attributable to Celanese Corporation
Engineered Materials 54 54 171 43 47 38 43
Acetate Tow 33 32 107 26 24 28 29
Acetyl Chain
Industrial Specialties 1
Acetyl Intermediates 2   2   6   2   1   2   1  
Subtotal 3   2   6   2   1   2   1  
Other Activities(2)   6   10   8   (4 ) 2   4  
Total 90   94   294   79   68   70   77  
Non-Operating Pension and Other Post-Retirement Employee Benefit (Expense) Income Attributable to Celanese Corporation
Engineered Materials
Acetate Tow
Acetyl Chain
Industrial Specialties 2 1 1
Acetyl Intermediates              
Subtotal     2   1   1      
Other Activities(2) 26   26   42   (24 ) 22   22   22  
Total 26   26   44   (23 ) 23   22   22  
Certain Items Attributable to Celanese Corporation (Table 8)
Engineered Materials 7 1 16 1 5 7 3
Acetate Tow 5 5 1 2 2
Acetyl Chain
Industrial Specialties 2 3 3
Acetyl Intermediates     61   1   7   (3 ) 56  
Subtotal 2     64   1   10   (3 ) 56  
Other Activities(2) 4   12   82   54   12   12   4  
Total 18   13   167   57   27   18   65  

___________________________

             

(1) Net earnings (loss) attributable to NCI is included within the Acetyl Intermediates segment.

(2) Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

 

Table 2 - Supplemental Segment Data and Reconciliation of Segment Adjusted EBIT and Operating EBITDA - Non-GAAP Measures - Unaudited (cont.)

 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17
(In $ millions, except percentages)
Adjusted EBIT / Adjusted EBIT Margin              
Engineered Materials 175 26.4 % 182 27.4 % 599 27.1 % 142 24.5 % 157 27.4 % 150 27.5 % 150 29.2 %
Acetate Tow 77 47.5 % 78 46.4 % 301 45.1 % 68 43.3 % 69 43.9 % 71 43.6 % 93 48.7 %
Acetyl Chain
Industrial Specialties 25 8.7 % 23 8.4 % 90 8.8 % 16 6.3 % 23 8.7 % 26 9.9 % 25 10.2 %
Acetyl Intermediates 252 29.3 % 231 26.5 % 485 18.2 % 162 22.6 % 134 19.6 % 106 16.3 % 83 13.4 %
Eliminations   (1 )          
Subtotal 277   26.4 % 253   24.1 % 575   17.1 % 178   20.0 % 157   18.2 % 132   16.0 % 108   13.6 %
Other Activities(2) (38 ) (39 ) (119 ) (36 ) (38 ) (27 ) (18 )
Total 491   26.6 % 474   25.6 % 1,356   22.1 % 352   22.1 % 345   22.0 % 326   21.6 % 333   22.6 %
Depreciation and Amortization Expense (1)
Engineered Materials 32 32 111 29 30 27 25
Acetate Tow 10 10 41 11 10 10 10
Acetyl Chain
Industrial Specialties 10 9 36 10 8 10 8
Acetyl Intermediates 26   26   105   27   26   26   26  

Subtotal

36   35   141   37   34   36   34  
Other Activities(2) 4   2   10   2   4   2   2  
Total 82   79   303   79   78   75   71  
Operating EBITDA / Operating EBITDA Margin
Engineered Materials 207 31.2 % 214 32.2 % 710 32.1 % 171 29.5 % 187 32.6 % 177 32.4 % 175 34.0 %
Acetate Tow 87 53.7 % 88 52.4 % 342 51.2 % 79 50.3 % 79 50.3 % 81 49.7 % 103 53.9 %
Acetyl Chain
Industrial Specialties 35 12.2 % 32 11.7 % 126 12.3 % 26 10.3 % 31 11.7 % 36 13.7 % 33 13.5 %
Acetyl Intermediates 278 32.3 % 257 29.5 % 590 22.1 % 189 26.4 % 160 23.4 % 132 20.3 % 109 17.6 %
Eliminations   (1 )          
Subtotal 313   29.8 % 288   27.4 % 716   21.2 % 215   24.2 % 191   22.1 % 168   20.3 % 142   17.9 %
Other Activities(2) (34 ) (37 ) (109 ) (34 ) (34 ) (25 ) (16 )
Total 573   31.1 % 553   29.9 % 1,659   27.0 % 431   27.1 % 423   27.0 % 401   26.6 % 404   27.5 %
 
___________________________
(1)  

Excludes accelerated depreciation and amortization expense, which amounts are included in Certain Items above. See Table 1 for details.

(2)

Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

 
             
Table 3
Adjusted Earnings (Loss) per Share - Reconciliation of a Non-GAAP Measure - Unaudited
 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17
 

per

share

 

per

share

 

per

share

 

per

share

 

per

share

 

per

share

 

per

share

(In $ millions, except per share data)
Earnings (loss) from continuing operations attributable to Celanese Corporation 344 2.52 365 2.68 856 6.19 204 1.50 230 1.68 239 1.72 183 1.30
Income tax provision (benefit) 97   65   213   60   57   40   56  
Earnings (loss) from continuing operations before tax 441 430 1,069 264 287 279 239

Certain Items attributable to Celanese Corporation (Table 8)

18   13   167   57   27   18   65  
Adjusted earnings (loss) from continuing operations before tax 459 443 1,236 321 314 297 304
Income tax (provision) benefit on adjusted earnings(1) (64 ) (62 ) (198 ) (51 ) (50 ) (48 ) (49 )
Adjusted earnings (loss) from continuing operations (2) 395   2.90   381   2.79   1,038   7.51   270   1.98   264   1.93   249   1.79   255   1.81
Diluted shares (in millions) (3)
Weighted average shares outstanding 135.6 135.9 137.9 135.8 136.6 138.6 140.6
Incremental shares attributable to equity awards 0.7   0.5   0.4   0.5   0.4   0.4   0.4  
Total diluted shares 136.3   136.4   138.3   136.3   137.0   139.0   141.0  
 

______________________________

(1) Calculated using adjusted effective tax rates (Table 3a) as follows:

 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17
(In percentages)
Adjusted effective tax rate 14 14 16 16 16 16 16
 

(2) Excludes the immediate recognition of actuarial gains and losses and the impact of actual vs. expected plan asset returns.

 
    Expected
Actual Plan Plan Asset
Asset Returns Returns
(In percentages)
2017 10.5 7.3

(3) Potentially dilutive shares are included in the adjusted earnings per share calculation when adjusted earnings are positive.

 
   
Table 3a
Adjusted Tax Rate - Reconciliation of a Non-GAAP Measure - Unaudited
 
Estimated Actual
2018 2017
(In percentages)
US GAAP annual effective tax rate 16 20
Discrete quarterly recognition of GAAP items(1) (3 ) (11 )
Tax impact of other charges and adjustments(2) (2 ) 1
Utilization of foreign tax credits 20
Changes in valuation allowances, excluding impact of other charges and adjustments(3) 2 (13 )
Other(4) 1   (1 )
Adjusted tax rate 14   16  
 
______________________________

Note: As part of the year-end reconciliation, we will update the reconciliation of the GAAP effective tax rate for actual results.

(1) Such as changes in tax laws (including US tax reform), deferred taxes on outside basis differences, changes in uncertain tax positions and prior year audit adjustments.

(2) Reflects the tax impact on pre-tax adjustments presented in Certain Items (Table 8), which are excluded from pre-tax income for adjusted earnings per share purposes.

(3) Reflects changes in valuation allowances related to changes in judgment regarding the realizability of deferred tax assets or current year operations, excluding other charges and adjustments.

(4) Tax impacts related to full-year forecasted tax opportunities and related costs.

 
             
Table 4
Net Sales by Segment - Unaudited
 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17
(In $ millions)
Engineered Materials 664 665 2,213 580 573 546 514
Acetate Tow 162 168 668 157 157 163 191
Acetyl Chain
Industrial Specialties 288 274 1,023 252 264 262 245
Acetyl Intermediates 861 871 2,669 717 684 649 619
Eliminations(1) (100 ) (94 ) (321 ) (81 ) (85 ) (85 ) (70 )
Subtotal 1,049   1,051   3,371   888   863   826   794  
Other Activities(2)
Intersegment eliminations(1) (31 ) (33 ) (112 ) (32 ) (27 ) (25 ) (28 )
Net sales 1,844   1,851   6,140   1,593   1,566   1,510   1,471  
 

___________________________

(1) Includes intersegment sales as follows:

 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17
(In $ millions)
Acetate Tow (2 ) (2 )
Industrial Specialties (1 ) (2 ) (4 ) (1 ) (1 ) (1 ) (1 )
Acetyl Intermediates (130 ) (125 ) (427 ) (110 ) (111 ) (109 ) (97 )
Intersegment eliminations (131 ) (127 ) (433 ) (113 ) (112 ) (110 ) (98 )
 

(2) Other Activities includes corporate SG&A expenses, the results of captive insurance companies and certain components of net periodic benefit cost (interest cost, expected return on plan assets and net actuarial gains and losses).

 
         

Table 4a

Factors Affecting Segment Net Sales Sequentially - Unaudited

 

Three Months Ended June 30, 2018 Compared to Three Months Ended March 31, 2018

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials (1 ) 3 (2 )
Acetate Tow (3 ) (1 ) (4 )
 
Industrial Specialties 6 1 (2 ) 5
Acetyl Intermediates (4 ) 4 (1 ) (1 )
Acetyl Chain (2 ) 4 (1 ) (1 )
 
Total Company (2 ) 3 (1 )
 

Three Months Ended March 31, 2018 Compared to Three Months Ended December 31, 2017

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials 10 3 2 15

(1)

Acetate Tow 8 8
 
Industrial Specialties 5 1 3 9
Acetyl Intermediates 9 11 2 22
Acetyl Chain 8 9 3 (2 ) 18
 
Total Company 9 6 2 (1 ) 16
 

Three Months Ended December 31, 2017 Compared to Three Months Ended September 30, 2017

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials (8 ) 9 1
Acetate Tow 2 (2 )
 
Industrial Specialties (6 ) 1 (5 )
Acetyl Intermediates (4 ) 9 5
Acetyl Chain (5 ) 7 1 3
 
Total Company (5 ) 7 2
 
         

Three Months Ended September 30, 2017 Compared to Three Months Ended June 30, 2017

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials 1 1 3 5
Acetate Tow (5 ) 1 (4 )
 
Industrial Specialties (4 ) 2 3 1
Acetyl Intermediates 3 (1 ) 3 5
Acetyl Chain 1 3 4
 
Total Company 1 3 4
 

Three Months Ended June 30, 2017 Compared to Three Months Ended March 31, 2017

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials 4 2 6 (2)
Acetate Tow (12 ) (3 ) (15 )
 
Industrial Specialties 2 3 2 7
Acetyl Intermediates (1 ) 5 1 5
Acetyl Chain 5 1 (2 ) 4
 
Total Company 3 1 (1 ) 3
 

Three Months Ended March 31, 2017 Compared to Three Months Ended December 31, 2016

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials 33 (1 ) 32 (3)
Acetate Tow 2 (6 ) (4 )
 
Industrial Specialties 11 1 12
Acetyl Intermediates (2 ) 6 4
Acetyl Chain 2 5 (1 ) 6
 
Total Company 11 2 (1 ) 12
 
___________________________
(1)  

2018 includes the effect of the acquisition of Omni Plastics, L.L.C.

(2)

2017 includes the effect of the acquisition of the nylon compounding division of Nilit Group.

(3)

2017 includes the effect of the SO.F.TER. S.p.A. acquisition.

 
         
Table 4b

Factors Affecting Segment Net Sales Year Over Year - Unaudited

 

Three Months Ended June 30, 2018 Compared to Three Months Ended June 30, 2017

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials 11 7 4 22
Acetate Tow 1 (2 ) (1 )
 
Industrial Specialties 5 5 10
Acetyl Intermediates 8 22 4 (1 ) 33
Acetyl Chain 6 19 5 (3 ) 27
 
Total Company 7 13 4 (2 ) 22
 

Three Months Ended March 31, 2018 Compared to Three Months Ended March 31, 2017

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials 19 3 7 29
Acetate Tow (9 ) (4 ) 1 (12 )
 
Industrial Specialties (3 ) 7 8 12
Acetyl Intermediates 5 30 6 41
Acetyl Chain 3 25 7 (3 ) 32
 
Total Company 7 14 6 (1 ) 26
 

Three Months Ended December 31, 2017 Compared to Three Months Ended December 31, 2016

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials 45 4 49
Acetate Tow (14 ) (9 ) 1 1 (21 )
 
Industrial Specialties 3 7 5 15
Acetyl Intermediates (4 ) 21 3 20
Acetyl Chain (2 ) 19 4 (2 ) 19
 
Total Company 10 10 3 (1 ) 22
 
         

Three Months Ended September 30, 2017 Compared to Three Months Ended September 30, 2016

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials 45 (2 ) 2

45

Acetate Tow (12 ) (8 ) 1

(19

)

 
Industrial Specialties 2 4 2 8
Acetyl Intermediates (1 ) 16 1 16
Acetyl Chain 13 2 (2 ) 13
 
Total Company 11 6 2 (1 ) 18
 

Three Months Ended June 30, 2017 Compared to Three Months Ended June 30, 2016

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials 42 (2 ) (1 ) 39
Acetate Tow (13 ) (9 )

(22

)

 
Industrial Specialties (1 ) 3 (2 )
Acetyl Intermediates (4 ) 14 (1 ) 1 10
Acetyl Chain (3 ) 12 (2 ) (1 ) 6
 
Total Company 8 5 (1 ) 12
 

Three Months Ended March 31, 2017 Compared to Three Months Ended March 31, 2016

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials 43 (4 ) (2 ) 37
Acetate Tow (6 ) (7 )

(13

)

 
Industrial Specialties 1 (2 ) (2 ) (3

)

Acetyl Intermediates (12 ) 7 (2 )

(7

)

Acetyl Chain (9 ) 5 (2 ) 1

(5

)

 
Total Company 5 1 (2 ) 1 5
 
         
Table 4c
Factors Affecting Segment Net Sales Year Over Year - Unaudited
 

Year Ended December 31, 2017 Compared to Year Ended December 31, 2016

 
Volume Price Currency Other Total
(In percentages)
Engineered Materials 44 (2 ) 1 43
Acetate Tow (11 ) (8 ) (19 )
 
Industrial Specialties 1 3 4
Acetyl Intermediates (5 ) 14 9
Acetyl Chain (4 ) 12 8
 

Total Company

9 5 14
 
             

Table 5

Free Cash Flow - Reconciliation of a Non-GAAP Measure - Unaudited

 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17
(In $ millions)
Net cash provided by (used in) investing activities (96 ) (235 ) (549 ) (92 ) (68 ) (325 ) (64 )
Net cash provided by (used in) financing activities (254 ) (2 ) (351 ) 145 (247 ) 21 (270 )
 
Net cash provided by (used in) operating activities 585 143 803 58 255 298 192
Capital expenditures on property, plant and equipment (79 ) (86 ) (267 ) (87 ) (64 ) (54 ) (62 )
Capital (distributions to) contributions from NCI (6 ) (2 ) (27 ) (9 ) (10 ) (4 ) (4 )
Free cash flow (1)(2) 500   55   509   (38 ) 181   240   126  
 
Net sales 1,844   1,851   6,140   1,593   1,566   1,510   1,471  
 
Free cash flow as % of Net sales 27.1 % 3.0 % 8.3 % (2.4 )% 11.6 % 15.9 % 8.6 %
 
______________________________
(1)  

Free cash flow is a liquidity measure used by the Company and is defined by the Company as net cash provided by (used in) operating activities, less capital expenditures on property, plant and equipment, and adjusted for capital contributions from or distributions to Mitsui & Co., Ltd. ("Mitsui") related to our joint venture, Fairway Methanol LLC ("Fairway").

(2)

Excludes required debt service and capital lease payments of $63 million and $27 million for the years ending December 31, 2018 and 2017, respectively.

 
             
Table 6
Cash Dividends Received - Unaudited
 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17
(In $ millions)
Dividends from equity method investments 39 76 131 17 5 59 50
Dividends from cost method investments 34   32   108   26   24   29   29  
Total 73   108   239   43   29   88   79  
 

Table 7

Net Debt - Reconciliation of a Non-GAAP Measure - Unaudited

 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17
(In $ millions)
Short-term borrowings and current installments of long-term debt - third party and affiliates 366 425 326 326 435 384 107
Long-term debt, net of unamortized deferred financing costs 3,228   3,343   3,315   3,315   2,954   2,931   2,851  
Total debt 3,594 3,768 3,641 3,641 3,389 3,315 2,958
Cash and cash equivalents (708 ) (490 ) (576 ) (576 ) (461 ) (511 ) (501 )
Net debt 2,886   3,278   3,065   3,065   2,928   2,804   2,457  
 
               
Table 8
Certain Items - Unaudited
 

The following Certain Items attributable to Celanese Corporation are included in Net earnings (loss) and are adjustments to non-GAAP measures:

 
Q2 '18 Q1 '18 2017 Q4 '17 Q3 '17 Q2 '17 Q1 '17 Income Statement Classification
(In $ millions)
Plant/office closures 3 58 2 2 (3 ) 57 Cost of sales / SG&A / R&D / Other charges (gains), net
Mergers and acquisitions 11 13 35 9 10 7 9 Cost of sales / SG&A / Other income (expense), net

Impact from natural disasters(1)

11 11 Cost of sales

InfraServ ownership change

8 8 Other charges (gains), net / Equity in net earnings (loss) of affiliates

Actuarial (gain) loss on pension and postretirement plans

46 46

Cost of sales / SG&A / R&D

Restructuring 3 9 4 3 2 Cost of sales / SG&A / R&D / Other charges (gains), net
Other 1           3   (3 ) (Gain) loss on disposition, net / Equity in net earnings (loss) of affiliates
Certain Items attributable to Celanese Corporation 18   13   167   57   27   18   65  

______________________________

(1) Primarily associated with Hurricane Harvey.

 
     

Table 9

Return on Invested Capital (Adjusted) - Presentation of a Non-GAAP Measure - Unaudited

 

 

2017

(In $ millions,

except percentages)

Net earnings (loss) attributable to Celanese Corporation 843
 

Adjusted EBIT (Table 1)

1,356

Adjusted effective tax rate (Table 3a)

16 %
Adjusted EBIT tax effected 1,139
 
2017 2016 Average
(In $ millions, except percentages)
Short-term borrowings and current installments of long-term debt - third parties and affiliates 326 118 222
Long-term debt, net of unamortized deferred financing costs 3,315 2,890 3,103
Celanese Corporation stockholders' equity 2,887 2,588 2,738  
Invested capital 6,063  
 
Return on invested capital (adjusted) 18.8 %
 
Net earnings (loss) attributable to Celanese Corporation as a percentage of invested capital 13.9 %
 

Celanese Corporation
Investor Relations
Surabhi Varshney, +1-972-443-3078
Surabhi.Varshney@celanese.com
or
Media - U.S.
Travis Jacobsen, +1-972-443-3750
William.Jacobsen@celanese.com
or
Media - Europe
Jens Kurth, +49(0)69 45009 1574
Jens.Kurth@celanese.com

Tags:


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today